T32 Research Training in Diabetes and Endocrinology
T32 Research Training in Diabetes and Endocrinology
批准号:
10649498
负责人:
ROBERT M O'DOHERTY
金额:
$34.22万
依托单位国家:
美国
项目类别:
财政年份:
1975
资助国家:
美国
项目状态:
未结题
起止时间:
1975-07-01 至 2027-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
7. PROJECT SUMMARY/ABSTRACT
This application is a competitive renewal of the training grant “Research Training in Diabetes and
Endocrinology,” which would represent years 47-51 of the first, and longest-running, T32 grant at the University
of Pittsburgh. The longevity is a testament to the success of the program in providing postdoctoral trainees with
the research/career skills necessary for developing independent academic careers. Over that time period, the
research landscape has changed dramatically, and this training program has adapted to complement the
changes. One notable and relatively recent change is the increased complexity of medical research, requiring
cross-discipline integration of research programs. This change necessitates that researchers operate in an
environment that provides a thorough grounding in the translational focus of medical research. Added to this is
the need for ever greater competency in the ancillary skills that are required to complement the core research
skills – including project, group, and multi-team collaboration management, grant writing, public presentations,
transitioning to independence, and others. Historically, these skills were often learned ‘on the fly’, but now
require a more structured approach. During the current cycle of the program we have worked assiduously to
implement such a program, which we believe has resulted in great success and outcomes. Thus, our trainees
are continuously immersed through hands-on-mentoring, peer-to-peer interactions, research experiences,
didactic classes, education workshops, and presentation opportunities in a truly integrated translational
research training program. At a practical level, this is reflected in (i) outstanding research opportunities that are
centered on three research hubs (basic, clinical, and public health/epidemiology); (ii) exceptional training
faculty with expertise in basic, clinical, and public health/epidemiology research; (iii) access to a range of
didactic courses, workshops, and educational experiences, including masters and certificate programs, that
buttress and complement research opportunities and, in many cases, emphasize translational themes; (iv)
structured career development courses that impart skills ranging from managing group projects to presentation
skills, through the T32-to-K-to-R grant transition; (v) a continuous assessment program for trainees, reinforced
by an Individual Career Development Plan, a 3-person mentoring team, and yearly progress evaluations by a
Training Committee that focuses on the individualized professional development of trainees; and (vi) program
management that oversees the ever-increasing complexity of research training in medical research, including
internal and external advisory boards. Our expectation over the next cycle of the training program is that we will
continue to train 4 postdoctoral fellows per year, with a mix of MDs and PhDs, and will offer two to three years
of support to each trainee. At the time of writing, 11 trainees have been supported by the training program in
the 2016-2021 cycle, and 8 have graduated (3 are still in training). Seven graduates applied for, or received,
competitive grant funding, 7 graduates remain active in research careers, and 3 obtained faculty positions.
Nineteen first author peer-reviewed publications were produced (43 total peer-reviewed publications), and 27
first author abstracts were presented at national scientific meetings. All 8 graduates published at least one first
author original research manuscript. Eighteen grants were submitted and 11 were funded. These metrics
represent concrete and categorical evidence of the continued success of our training program.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cost-effectiveness of empagliflozin versus weekly semaglutide as add-on therapy for Type 2 diabetes.
恩格列净与每周一次索马鲁肽作为 2 型糖尿病附加治疗的成本效益。
DOI:
10.2217/cer-2021-0016
发表时间:
2021
期刊:
Journal of comparative effectiveness research
影响因子:
2.1
作者:
[Zupa,MargaretF, Codario,RonaldA, Smith,KennethJ]
通讯作者:
Smith,KennethJ
The oxytocin secretory response during suckling in the hypoosmolar lactating rat.
低渗哺乳期大鼠哺乳期间催产素的分泌反应。
DOI:
10.1016/0006-8993(93)90611-p
发表时间:
1993
期刊:
Brain research
影响因子:
2.9
作者:
[Bononi,PL, Janosky,JE, Amico,JA]
通讯作者:
Amico,JA
DOI:
10.1210/me.2006-0178
发表时间:
2006-12
期刊:
Molecular endocrinology
影响因子:
--
作者:
[C. A. Syme;Lei Zhang;A. Bisello]
通讯作者:
C. A. Syme;Lei Zhang;A. Bisello
A Risk Stratification Approach to Allocating Diabetes Education and Support Services.
分配糖尿病教育和支持服务的风险分层方法。
DOI:
10.1089/dia.2021.0253
发表时间:
2022
期刊:
Diabetes technology & therapeutics
影响因子:
5.4
作者:
[Zupa,MargaretF, Krall,Jodie, Collins,Kevin, Marroquin,Oscar, Ng,JasonM, Siminerio,Linda]
通讯作者:
Siminerio,Linda
Effect of gonadal steroids upon hypothalamic oxytocin expression.
性腺类固醇对下丘脑催产素表达的影响。
DOI:
--
发表时间:
1995
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Amico,JA, Crowley,RS, Insel,TR, Thomas,A, O'Keefe,JA]
通讯作者:
O'Keefe,JA
共 11 条
Dendritic Cells and Obesity
-
批准号:9107446
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2015
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Dendritic Cells and Obesity
-
批准号:9293273
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2015
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:8006711
-
项目类别:
-
资助金额:$3.65万
-
财政年份:2010
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7265205
-
项目类别:
-
资助金额:$28.12万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8104928
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7457847
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7630409
-
项目类别:
-
资助金额:$27.56万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8236922
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8462594
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Hepatic Leptin Action and Leptin Resistance
-
批准号:7142795
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Leptin Action and Macrophages
-
批准号:8663884
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2006
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6498204
-
项目类别:
-
资助金额:$21.87万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids, Inflammatory Pathways, and Insulin Resistance
-
批准号:7632218
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids Inflammatory Pathways and Insulin Resistance
-
批准号:7148938
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids, Inflammatory Pathways, and Insulin Resistance
-
批准号:7429760
-
项目类别:
-
资助金额:$26.89万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6256417
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6628600
-
项目类别:
-
资助金额:$21.78万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Lipids, Inflammatory Pathways, and Insulin Resistance
-
批准号:7266224
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
LEPTIN INDUCED REVERSAL ON INSULIN RESISTANCE IN OBESITY
-
批准号:6703155
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2001
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
Research Training in Diabetes and Endocrinology
-
批准号:10115902
-
项目类别:
-
资助金额:$3.26万
-
财政年份:1975
-
负责人:ROBERT M O'DOHERTY
-
依托单位:
海外基金